The Global Stem Cell Factor (SCF) Market was valued at USD 12900 Million in 2023 and is anticipated to reach USD Million by ...

Stem cell transplant in young adults and adolescents with severe sickle cell disease may be a feasible option, according to a ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

Gene therapy and hematopoietic stem cell transplantation (HSCT) are two innovative approaches in the treatment of genetic disorders and blood-related diseases. Gene therapy involves modifying or ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to ...

(IN BRIEF) AstraZeneca’s Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ...

Stem cell therapy has come a long way since its early days. As an athlete who has undergone it twice, I know that the ...